Pembrolizumab and axitinib induced pathological complete response in metastatic clear cell renal cell carcinoma with ...
Clear cell renal cell carcinoma is the predominant subtype of kidney cancer. With distant metastasis, the overall survival rate for patients with renal cell carcinoma decreases significantly compared to localized disease. However, pembrolizumab plus …